CIK 0001526119
- Non-accelerated filer
- Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 273269467
- Phone
- +1 781-292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-03-06 | GADICKE ANSBERT Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2012-02-01 | GADICKE ANSBERT Director | Conversion | +1,142,857 | 1,142,857 | ||
| 2012-02-01 | GADICKE ANSBERT Director | Conversion | +714,286 | 1,857,143 | ||
| 2012-02-01 | GADICKE ANSBERT Director | Conversion | +76,190 | 1,933,333 | ||
| 2012-02-01 | GADICKE ANSBERT Director | Purchase | +96,260 | $10.00 | $963K | 2,029,593 |
| 2012-02-01 | GADICKE ANSBERT Director | Purchase | +3,740 | $10.00 | $37K | 3,740 |
| 2012-02-01 | GADICKE ANSBERT Director | Conversion · Series A Preferred Stock | −4,000,000 | 0 | ||
| 2012-02-01 | GADICKE ANSBERT Director | Conversion · Series B Preferred Stock | −2,500,000 | 0 | ||
| 2012-02-01 | GADICKE ANSBERT Director | Conversion · Series C Preferred Stock | −266,666 | 0 |
Page 1 of 1 · 9 trades